Home » Stocks » POAI

Predictive Oncology Inc. (POAI)

Stock Price: $1.42 USD -0.13 (-8.12%)
Updated Mar 4, 2021 11:15 AM EST - Market open
Market Cap 75.54M
Revenue (ttm) 1.31M
Net Income (ttm) -28.67M
Shares Out 15.21M
EPS (ttm) -3.42
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 4
Last Price $1.42
Previous Close $1.54
Change ($) -0.13
Change (%) -8.12%
Day's Open 1.38
Day's Range 1.30 - 1.49
Day's Volume 2,161,539
52-Week Range 0.63 - 4.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building Helomics Researchers Complete Key Sequencing Milestones and Focus on AI-Driven Model Building

GlobeNewsWire - 1 week ago

MINNEAPOLIS, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 2 weeks ago

MINNEAPOLIS, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and dr...

GlobeNewsWire - 2 weeks ago

MINNEAPOLIS, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 3 weeks ago

MINNEAPOLIS, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 3 weeks ago

MINNEAPOLIS, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and dr...

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 1 month ago

EAGAN, Minn., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and d...

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intel...

GlobeNewsWire - 1 month ago

Our new PeDAL fee-for-service offering for Pharmaceutical companies will significantly improve the chances of translating discoveries into the clinic Our new PeDAL fee-for-service offering for...

GlobeNewsWire - 1 month ago

MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and dr...

GlobeNewsWire - 2 months ago

Reincorporation Proposal Received Overwhelming Support Among Shares Voted Reincorporation Proposal Received Overwhelming Support Among Shares Voted

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug ...

GlobeNewsWire - 3 months ago

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug ...

GlobeNewsWire - 4 months ago

NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio — Predictive Oncology Inc. (NASDA Q : POAI) today announces that its chief executive officer, Carl Schwartz, has been featured ...

GlobeNewsWire - 4 months ago

EAGAN, Minn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ:POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and dr...

GlobeNewsWire - 5 months ago

Predictive Oncology now has a total of 96 unique Patient Derived Cells (PDCs) from Ovarian Cancer Patients. Predictive Oncology now has a total of 96 unique Patient Derived Cells (PDCs) from O...

GlobeNewsWire - 6 months ago

EAGAN, Minn., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine an...

GlobeNewsWire - 6 months ago

EAGAN, Minn., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and...

GlobeNewsWire - 6 months ago

EAGAN, Minn., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and...

GlobeNewsWire - 6 months ago

LOS ANGELES, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NetworkWire — Predictive Oncology Inc. (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to p...

GlobeNewsWire - 6 months ago

Increases Readiness for Commercialization with Expanded Portfolio of Solutions for Precision Medicine

GlobeNewsWire - 6 months ago

Annual Meeting of Stockholders to be Held on September 3, 2020 Annual Meeting of Stockholders to be Held on September 3, 2020

GlobeNewsWire - 7 months ago

Adds Industry, Business Development and Financial Expertise Adds Industry, Business Development and Financial Expertise

GlobeNewsWire - 7 months ago

Acquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development Acquisition Focused on Accelerating Commercialization of AI-driven Drug Discovery and Development

GlobeNewsWire - 8 months ago

MINNEAPOLIS, June 29, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (the “Company,” “Predictive Oncology,” “we,” “our” or “us”) (NASDAQ: POAI), a knowledge-driven company focused on appl...

GlobeNewsWire - 8 months ago

A Top US Medical Institution Places the First Commercial Order for the Media used to grow Ovarian Cancer Cell Types that are Exceedingly Difficult to Grow and Retain the Signatures of the Pati...

GlobeNewsWire - 8 months ago

CancerQuest 2020 Study on Schedule for Completion in Q2 2020 CancerQuest 2020 Study on Schedule for Completion in Q2 2020

GlobeNewsWire - 9 months ago

MINNEAPOLIS, June 02, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (the “Company”) a knowledge-driven company focused on applying artificial intelligence (“AI”) to person...

GlobeNewsWire - 9 months ago

MINNEAPOLIS, May 14, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI)  has, with the announced acquisition of Soluble Therapeutics and the subsequent partnership and licensing of ...

GlobeNewsWire - 9 months ago

MINNEAPOLIS, May 07, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial inte...

GlobeNewsWire - 9 months ago

MINNEAPOLIS, May 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI) has, with the announced acquisition of Soluble Therapeutics, Inc. and the subsequent partnership and licensin...

GlobeNewsWire - 10 months ago

CEO Agrees to Exchange $2.1 Million Promissory Note for Newly Issued Equity, Demonstrating Confidence in Company’s Future CEO Agrees to Exchange $2.1 Million Promissory Note for Newly Issued E...

GlobeNewsWire - 10 months ago

NEW YORK, April 22, 2020 (GLOBE NEWSWIRE) -- via NetworkNewsAudio — Predictive Oncology (NASDAQ: POAI) today announces that Company director and CEO Dr. Carl Schwartz, in an interview with ...

GlobeNewsWire - 11 months ago

MINNEAPOLIS, March 31, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI ) (“POAI” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“...

GlobeNewsWire - 11 months ago

MINNEAPOLIS, March 23, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery s...

GlobeNewsWire - 11 months ago

MINNEAPOLIS, March 16, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery s...

GlobeNewsWire - 11 months ago

With More Viral Outbreaks Expected, Predictive Oncology Expands AI Platforms to Aid in Vaccine and Drug Development With More Viral Outbreaks Expected, Predictive Oncology Expands AI Platforms...

GlobeNewsWire - 1 year ago

POAI proposed acquisition of Carnegie Mellon University spin-out Quantitative Medicine further positions the company to aid in efforts to accelerate the discovery of new anti-cancers, anti-vir...

GlobeNewsWire - 1 year ago

MINNEAPOLIS, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery se...

GlobeNewsWire - 1 year ago

New Formulations Will Speed Discovery of Biomarkers and Precision Therapies

GlobeNewsWire - 1 year ago

AI platform was developed at the Ray and Stephanie Lane Center for Computational Biology, which became the Computational Biology Department at Carnegie Mellon University and was successfully t...

GlobeNewsWire - 1 year ago

MINNEAPOLIS, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery se...

GlobeNewsWire - 1 year ago

MINNEAPOLIS, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery se...

About POAI

Predictive Oncology provides various healthcare products and services primarily in the United States. The company operates in three segments: Domestic, International, and Helomics. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' ex... [Read more...]

Industry
Medical Instruments & Supplies
Founded
2002
CEO
Carl Schwartz
Employees
29
Stock Exchange
NASDAQ
Ticker Symbol
POAI
Full Company Profile

Financial Performance

In 2019, POAI's revenue was $1.41 million, a decrease of -0.01% compared to the previous year's $1.41 million. Losses were -$19.39 million, 92.2% more than in 2018.

Financial Statements